Skip to main navigation Skip to search Skip to main content

Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis

  • Kyung Jong Lee
  • , Man Pyo Chung
  • , Young Whan Kim
  • , Jae Ho Lee
  • , Kyu Sik Kim
  • , Jeong Seon Ryu
  • , Hong Lyeol Lee
  • , Sung Woo Park
  • , Choon Sik Park
  • , Soo Tak Uh
  • , Yong Chul Lee
  • , Seoung Ju Park
  • , Kwan Hyoung Kim
  • , Young June Jeon
  • , Won Il Choi
  • , Yong Bum Park
  • , Dong Soon Kim
  • , Sung Hwan Jeong
  • , Jin Hwa Lee
  • , Moo Suk Park*
  • *Corresponding author for this work
  • Sungkyunkwan University
  • Seoul National University
  • Chonnam National University
  • Inha University
  • Soonchunhyang University
  • Jeonbuk National University
  • The Catholic University of Korea
  • Keimyung University
  • Hallym University
  • University of Ulsan
  • Gachon University
  • Ewha Womans University
  • Yonsei University

Research output: Contribution to journalJournal articlepeer-review

Abstract

Background: The aim of this study was to evaluate the prevalence, risk factors, and survival of lung cancer in patients with idiopathic pulmonary fibrosis (IPF). Methods: IPF with lung cancer from tertiary hospitals consisted of 1685 patients who had been diagnosed between 2003 and 2007.We reviewed their medical records retrospectively to evaluate the prevalence, risk factors and prognosis of lung cancer in IPF patients. Results: Among all patients with IPF, 114 cases (6.8%) had lung cancer with IPF. The incidence of lung cancer in patients with IPF was 1.03 persons per 100 person-year (25 patients/2408 years). Most cases of lung cancer (73/114, 68.9%) were located in IPF-associated areas; the lung cancer typically developed in peripheral and lower lobe areas. The study revealed that forced vital capacity (%predicted) at the initial diagnosis and development of lung cancerwere independent prognostic factors in patients with IPF. Conclusions: Lung cancer in patientswith IPF was significantly relatedwith the IPF prognosis. An active evaluation should be performed in patients with IPF to detect lung cancer early.

Original languageEnglish
Pages (from-to)150-155
Number of pages6
JournalThoracic Cancer
Volume3
Issue number2
DOIs
StatePublished - 2012.05

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Idiopathic pulmonary fibrosis
  • Lung cancer
  • Prevalence

Quacquarelli Symonds(QS) Subject Topics

  • Medicine

Fingerprint

Dive into the research topics of 'Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Cite this